UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival

Pulmonary circulation, 2023-04, Vol.13 (2), p.e12235-n/a

2023

Volltextzugriff (PDF)

Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension—A pilot study

Pulmonary circulation, 2023-04, Vol.13 (2), p.e12232-n/a

2023

Volltextzugriff (PDF)

Quantifying the impact of post‐acute sequelae of coronavirus on the cardiopulmonary endurance of athletes

Pulmonary circulation, 2024-07, Vol.14 (3), p.e12413-n/a

2024

Volltextzugriff (PDF)

Caveolin‐1 associated with severe (pediatric‐onset) presentation of pulmonary arterial hypertension

Pulmonary circulation, 2022-07, Vol.12 (3), p.e12100-n/a

2022

Volltextzugriff (PDF)

Liver abnormalities in pulmonary arterial hypertension

Pulmonary Circulation, 2021-10, Vol.11 (4), p.1-12

2021

Volltextzugriff (PDF)

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival

Pulmonary circulation, 2023-07, Vol.13 (3), p.e12284-n/a

2023

Volltextzugriff (PDF)

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms

Pulmonary circulation, 2023-01, Vol.13 (1), p.e12185-n/a

2023

Volltextzugriff (PDF)

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity

Pulmonary circulation, 2022-04, Vol.12 (2), p.e12039-n/a

2022

Volltextzugriff (PDF)

Gender, sex hormones and pulmonary hypertension

Pulmonary Circulation, 2013-04, Vol.3 (2), p.294-314

2013

Volltextzugriff (PDF)

Estrogen metabolites in a small cohort of patients with idiopathic pulmonary arterial hypertension

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-5

2020

Volltextzugriff (PDF)

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension

Pulmonary circulation, 2019-07, Vol.9 (3), p.1-8

2019

Volltextzugriff (PDF)

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival

Pulmonary circulation, 2022-01, Vol.12 (1), p.e12007-n/a

2022

Volltextzugriff (PDF)

Novel early life risk factors for adult pulmonary hypertension

Pulmonary circulation, 2019-04, Vol.9 (2), p.1-4

2019

Volltextzugriff (PDF)

Low-grade albuminuria in pulmonary arterial hypertension

Pulmonary circulation, 2019-04, Vol.9 (2), p.1-9

2019

Volltextzugriff (PDF)

Sex hormone exposure and reproductive factors in pulmonary arterial hypertension: a case–control study

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-9

2020

Volltextzugriff (PDF)

A checkpoint on innate myeloid cells in pulmonary arterial hypertension

Pulmonary circulation, 2019-01, Vol.9 (1), p.1-5

2019

Volltextzugriff (PDF)

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

Pulmonary circulation, 2019-04, Vol.9 (2), p.1-8

2019

Volltextzugriff (PDF)

The genetics of pulmonary arterial hypertension in the post-BMPR2 era

Pulmonary Circulation, 2011-07, Vol.1 (3), p.305-319

2011

Volltextzugriff (PDF)

Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension

Pulmonary circulation, 2017-03, Vol.7 (1), p.186-199

2017

Volltextzugriff (PDF)

Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension

Pulmonary circulation, 2014-06, Vol.4 (2), p.311-318

2014

Volltextzugriff (PDF)

Pulmonary hypertension’s variegated landscape: a snapshot

Pulmonary Circulation, 2017-01, Vol.7 (1), p.67-81

2017

Volltextzugriff (PDF)

Shared Gene Expression Patterns in Mesenchymal Progenitors Derived from Lung and Epidermis in Pulmonary Arterial Hypertension: Identifying Key Pathways in Pulmonary Vascular Disease

Pulmonary circulation, 2016-12, Vol.6 (4), p.483-497

2016

Volltextzugriff (PDF)

Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function

Pulmonary circulation, 2013-09, Vol.3 (3), p.589-598

2013

Volltextzugriff (PDF)

Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression

Pulmonary circulation, 2011-07, Vol.1 (3), p.389-398

2011

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

KollektionUniversity of Chicago Press Journals (Full run)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Pulmonary Circulation
(27)

Menü

Weitere Dienste

Einstellungen

Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival

Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension—A pilot study

Quantifying the impact of post‐acute sequelae of coronavirus on the cardiopulmonary endurance of athletes

Caveolin‐1 associated with severe (pediatric‐onset) presentation of pulmonary arterial hypertension

Liver abnormalities in pulmonary arterial hypertension

Kids Mod PAH trial: A multicenter trial comparing mono‐ versus duo‐therapy for initial treatment of pediatric pulmonary hypertension

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms

Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity

Gender, sex hormones and pulmonary hypertension

Estrogen metabolites in a small cohort of patients with idiopathic pulmonary arterial hypertension

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival

Novel early life risk factors for adult pulmonary hypertension

Low-grade albuminuria in pulmonary arterial hypertension

Sex hormone exposure and reproductive factors in pulmonary arterial hypertension: a case–control study

A checkpoint on innate myeloid cells in pulmonary arterial hypertension

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications

The genetics of pulmonary arterial hypertension in the post-BMPR2 era

Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension

Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension

Pulmonary hypertension’s variegated landscape: a snapshot

Shared Gene Expression Patterns in Mesenchymal Progenitors Derived from Lung and Epidermis in Pulmonary Arterial Hypertension: Identifying Key Pathways in Pulmonary Vascular Disease

Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function

Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression

Aktive Filter

Suchergebnisse filtern